Home
About Us
About Us
Our Team
News & Press
Why Ultra-Rare Diseases
Our Model
Therapy Tracker
Contact
Select Page
Repurposing Screen
Back to Therapy Pipeline
Submitting Organization:
Cri du Chat Research Foundation
Treatment Modality:
Small Molecule (novel)
Development Stage:
Preclinical Phase - Target Validation